

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 6.20551282 |
| 2 | positive regulation of granulocyte differentiation (GO:0030854) | 5.40074436 |
| 3 | regulation of platelet aggregation (GO:0090330) | 5.14132633 |
| 4 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.89045569 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.61928369 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.50890313 |
| 7 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.48118296 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.47858396 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.34067366 |
| 10 | regulation of platelet activation (GO:0010543) | 4.31858679 |
| 11 | megakaryocyte development (GO:0035855) | 4.29015686 |
| 12 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.28466554 |
| 13 | cell communication by electrical coupling (GO:0010644) | 4.28007100 |
| 14 | plasma membrane repair (GO:0001778) | 4.26846443 |
| 15 | definitive hemopoiesis (GO:0060216) | 4.22071828 |
| 16 | cell communication involved in cardiac conduction (GO:0086065) | 4.20914707 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17910825 |
| 18 | sodium ion export (GO:0071436) | 4.17507958 |
| 19 | platelet aggregation (GO:0070527) | 4.14701713 |
| 20 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.13556800 |
| 21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.11502604 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.08058182 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.01698026 |
| 24 | regulation of membrane repolarization (GO:0060306) | 3.91892407 |
| 25 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.87003153 |
| 26 | activation of protein kinase A activity (GO:0034199) | 3.84017489 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 3.82476847 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.81501103 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.78800006 |
| 30 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.78230294 |
| 31 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.78230294 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 3.74931913 |
| 33 | carnitine shuttle (GO:0006853) | 3.66443575 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.66204880 |
| 35 | cardiac myofibril assembly (GO:0055003) | 3.64094889 |
| 36 | sarcomere organization (GO:0045214) | 3.63713222 |
| 37 | angiogenesis involved in wound healing (GO:0060055) | 3.61769020 |
| 38 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.61573856 |
| 39 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.54244526 |
| 40 | synaptic vesicle maturation (GO:0016188) | 3.54142957 |
| 41 | potassium ion export (GO:0071435) | 3.54097963 |
| 42 | regulation of female receptivity (GO:0045924) | 3.53257305 |
| 43 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.52670967 |
| 44 | relaxation of cardiac muscle (GO:0055119) | 3.52533153 |
| 45 | cellular potassium ion homeostasis (GO:0030007) | 3.50438297 |
| 46 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.49329456 |
| 47 | cardiac muscle contraction (GO:0060048) | 3.48444520 |
| 48 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.48421649 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.47527212 |
| 50 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.41539426 |
| 51 | protein targeting to Golgi (GO:0000042) | 3.40806916 |
| 52 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.38285856 |
| 53 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.32804232 |
| 54 | membrane depolarization during action potential (GO:0086010) | 3.31957216 |
| 55 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.31282130 |
| 56 | regulation of synapse structural plasticity (GO:0051823) | 3.31128790 |
| 57 | positive regulation of mast cell activation (GO:0033005) | 3.30815513 |
| 58 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.30813961 |
| 59 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.28770983 |
| 60 | myeloid cell development (GO:0061515) | 3.23562257 |
| 61 | blood coagulation, intrinsic pathway (GO:0007597) | 3.19387671 |
| 62 | detection of calcium ion (GO:0005513) | 3.15982333 |
| 63 | potassium ion import (GO:0010107) | 3.13919532 |
| 64 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.13025784 |
| 65 | membrane repolarization (GO:0086009) | 3.12642408 |
| 66 | myofibril assembly (GO:0030239) | 3.11392224 |
| 67 | regulation of granulocyte differentiation (GO:0030852) | 3.10615856 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09573880 |
| 69 | establishment of protein localization to Golgi (GO:0072600) | 3.09117739 |
| 70 | protein neddylation (GO:0045116) | 3.08316323 |
| 71 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.07804095 |
| 72 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.07411844 |
| 73 | fatty acid transmembrane transport (GO:1902001) | 3.07114733 |
| 74 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.05538087 |
| 75 | homotypic cell-cell adhesion (GO:0034109) | 3.04098280 |
| 76 | neutrophil activation (GO:0042119) | 3.03651664 |
| 77 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.03464067 |
| 78 | negative regulation of cell killing (GO:0031342) | 3.03464067 |
| 79 | negative thymic T cell selection (GO:0045060) | 3.03334275 |
| 80 | negative T cell selection (GO:0043383) | 3.03322485 |
| 81 | regulation of ARF protein signal transduction (GO:0032012) | 3.03320825 |
| 82 | positive regulation of potassium ion transport (GO:0043268) | 3.02381935 |
| 83 | tricarboxylic acid cycle (GO:0006099) | 3.01841977 |
| 84 | striatum development (GO:0021756) | 3.01534870 |
| 85 | cardiac conduction (GO:0061337) | 3.00264884 |
| 86 | female mating behavior (GO:0060180) | 2.99897793 |
| 87 | regulation of regulatory T cell differentiation (GO:0045589) | 2.98252034 |
| 88 | membrane repolarization during action potential (GO:0086011) | 2.97405432 |
| 89 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.97245935 |
| 90 | interkinetic nuclear migration (GO:0022027) | 2.97115424 |
| 91 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.96753778 |
| 92 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.96753778 |
| 93 | autophagic vacuole fusion (GO:0000046) | 2.96615996 |
| 94 | positive regulation of sodium ion transport (GO:0010765) | 2.95734907 |
| 95 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.95275166 |
| 96 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.94803735 |
| 97 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.93962917 |
| 98 | cardiac muscle cell action potential (GO:0086001) | 2.91945885 |
| 99 | regulation of cell communication by electrical coupling (GO:0010649) | 2.91735004 |
| 100 | regulation of B cell differentiation (GO:0045577) | 2.91595107 |
| 101 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.91500803 |
| 102 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.89551769 |
| 103 | leukocyte degranulation (GO:0043299) | 2.89120351 |
| 104 | negative regulation of neurotransmitter transport (GO:0051589) | 2.88471837 |
| 105 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.88424355 |
| 106 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.87968973 |
| 107 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.86385914 |
| 108 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.86350365 |
| 109 | negative regulation of potassium ion transport (GO:0043267) | 2.85977159 |
| 110 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.85932485 |
| 111 | positive T cell selection (GO:0043368) | 2.85856512 |
| 112 | negative regulation of interleukin-17 production (GO:0032700) | 2.84886000 |
| 113 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.84188371 |
| 114 | platelet activation (GO:0030168) | 2.83280729 |
| 115 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.82313064 |
| 116 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.81722831 |
| 117 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.81443376 |
| 118 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.81338281 |
| 119 | platelet formation (GO:0030220) | 2.80670737 |
| 120 | relaxation of muscle (GO:0090075) | 2.79927306 |
| 121 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.79876216 |
| 122 | positive thymic T cell selection (GO:0045059) | 2.79372256 |
| 123 | proline transport (GO:0015824) | 2.78782714 |
| 124 | regulation of integrin activation (GO:0033623) | 2.78726516 |
| 125 | potassium ion homeostasis (GO:0055075) | 2.78552015 |
| 126 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.77985257 |
| 127 | negative regulation of norepinephrine secretion (GO:0010700) | 2.77481878 |
| 128 | synaptic vesicle exocytosis (GO:0016079) | 2.76594068 |
| 129 | vesicle transport along microtubule (GO:0047496) | 2.74486229 |
| 130 | positive regulation of macrophage differentiation (GO:0045651) | 2.73665753 |
| 131 | adenosine receptor signaling pathway (GO:0001973) | 2.73421845 |
| 132 | nerve growth factor signaling pathway (GO:0038180) | 2.72970030 |
| 133 | negative regulation of platelet activation (GO:0010544) | 2.72244444 |
| 134 | regulation of synaptic vesicle transport (GO:1902803) | 2.72123924 |
| 135 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.71558847 |
| 136 | striated muscle contraction (GO:0006941) | 2.70423431 |
| 137 | carnitine transmembrane transport (GO:1902603) | 2.69937209 |
| 138 | cardiac muscle cell development (GO:0055013) | 2.69186133 |
| 139 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.68875258 |
| 140 | organelle membrane fusion (GO:0090174) | 2.68514672 |
| 141 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.68353550 |
| 142 | regulation of relaxation of muscle (GO:1901077) | 2.67824110 |
| 143 | protein targeting to plasma membrane (GO:0072661) | 2.67161624 |
| 144 | layer formation in cerebral cortex (GO:0021819) | 2.66318095 |
| 145 | regulation of cation channel activity (GO:2001257) | 2.65600063 |
| 146 | regulation of skeletal muscle contraction (GO:0014819) | 2.65226687 |
| 147 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.64803452 |
| 148 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.64671780 |
| 149 | response to pheromone (GO:0019236) | 2.64089767 |
| 150 | actomyosin structure organization (GO:0031032) | 2.63361221 |
| 151 | regulation of erythrocyte differentiation (GO:0045646) | 2.62761791 |
| 152 | purinergic receptor signaling pathway (GO:0035587) | 2.62460365 |
| 153 | glutamate secretion (GO:0014047) | 2.62305014 |
| 154 | positive regulation of hemostasis (GO:1900048) | 2.61795917 |
| 155 | positive regulation of blood coagulation (GO:0030194) | 2.61795917 |
| 156 | response to interleukin-15 (GO:0070672) | 2.60855135 |
| 157 | myeloid cell activation involved in immune response (GO:0002275) | 2.60725787 |
| 158 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.60294063 |
| 159 | mast cell activation (GO:0045576) | 2.59350519 |
| 160 | mast cell activation involved in immune response (GO:0002279) | 2.59264614 |
| 161 | mast cell degranulation (GO:0043303) | 2.59264614 |
| 162 | granulocyte activation (GO:0036230) | 2.59244316 |
| 163 | positive regulation of cation channel activity (GO:2001259) | 2.58800394 |
| 164 | endothelium development (GO:0003158) | 2.58735766 |
| 165 | negative regulation of heart contraction (GO:0045822) | 2.58463931 |
| 166 | relaxation of smooth muscle (GO:0044557) | 2.57819422 |
| 167 | locomotory exploration behavior (GO:0035641) | 2.57795521 |
| 168 | regulation of lipoprotein metabolic process (GO:0050746) | 2.57142272 |
| 169 | positive regulation of T cell cytokine production (GO:0002726) | 2.56856227 |
| 170 | lipoxygenase pathway (GO:0019372) | 2.56562370 |
| 171 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.56300809 |
| 172 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.55866648 |
| 173 | cellular sodium ion homeostasis (GO:0006883) | 2.55799489 |
| 174 | regulation of mast cell activation (GO:0033003) | 2.55708309 |
| 175 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.54988053 |
| 176 | regulation of mast cell degranulation (GO:0043304) | 2.53759144 |
| 177 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.53758042 |
| 178 | response to caffeine (GO:0031000) | 2.53576619 |
| 179 | cardiac cell development (GO:0055006) | 2.51972219 |
| 180 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.51807816 |
| 181 | negative regulation of inclusion body assembly (GO:0090084) | 2.51370440 |
| 182 | regulation of sodium ion transport (GO:0002028) | 2.50434760 |
| 183 | negative regulation of T cell apoptotic process (GO:0070233) | 2.46955964 |
| 184 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.46257195 |
| 185 | regulation of the force of heart contraction (GO:0002026) | 2.45935355 |
| 186 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.45703531 |
| 187 | cell migration in hindbrain (GO:0021535) | 2.45684986 |
| 188 | platelet degranulation (GO:0002576) | 2.44974805 |
| 189 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.44305679 |
| 190 | cellular extravasation (GO:0045123) | 2.44057785 |
| 191 | hepatocyte apoptotic process (GO:0097284) | 2.42605193 |
| 192 | phospholipid scrambling (GO:0017121) | 2.42091703 |
| 193 | microglial cell activation (GO:0001774) | 2.38788700 |
| 194 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.38326456 |
| 195 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.38198874 |
| 196 | mature B cell differentiation involved in immune response (GO:0002313) | 2.37397314 |
| 197 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.37396311 |
| 198 | positive regulation of coagulation (GO:0050820) | 2.35452807 |
| 199 | positive regulation of isotype switching (GO:0045830) | 2.33365453 |
| 200 | regulation of mitochondrial depolarization (GO:0051900) | 2.33290975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.81831606 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.43846658 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.83339672 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.62918875 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.22885812 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21560672 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.79197274 |
| 8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73830433 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60859019 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.46544477 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.41146971 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.26795050 |
| 13 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.21579582 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17908825 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17706616 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.15935945 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14727186 |
| 18 | GATA2_19941826_ChIP-Seq_K562_Human | 2.12848581 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12344093 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.11845346 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.10363296 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.05527720 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03285386 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.02580830 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.01821559 |
| 26 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.97766321 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.91367000 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87805035 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84947191 |
| 30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.84688703 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84440734 |
| 32 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.83237183 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.80125252 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.80024265 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.76626347 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.74460691 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.73436119 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71417094 |
| 39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71048564 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70517831 |
| 41 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70517831 |
| 42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.70329470 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.69557097 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69111565 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.67636610 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61969592 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59642601 |
| 48 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.59539375 |
| 49 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.54950485 |
| 50 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.54950485 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52756215 |
| 52 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52586875 |
| 53 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.52536901 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.51395300 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50221083 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49057985 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48093343 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47672813 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45724527 |
| 60 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45139451 |
| 61 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.45113876 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.43091330 |
| 63 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.42317513 |
| 64 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41423816 |
| 65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.41327021 |
| 66 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39862881 |
| 67 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.39779618 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39587422 |
| 69 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.38880103 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37258761 |
| 71 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36807840 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36806242 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36379641 |
| 74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.33943859 |
| 75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.33943859 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32856466 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32077610 |
| 78 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32038070 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31790899 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31582383 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30487648 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.30407950 |
| 83 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.29183481 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28740454 |
| 85 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28607690 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28587429 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26828092 |
| 88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26660312 |
| 89 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.26388059 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23334652 |
| 91 | AR_19668381_ChIP-Seq_PC3_Human | 1.23286775 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22427206 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22270258 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22074231 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22005645 |
| 96 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21976608 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21584830 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21404835 |
| 99 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21304577 |
| 100 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.20780544 |
| 101 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.20742507 |
| 102 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.20563324 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.20294108 |
| 104 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20079290 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19980305 |
| 106 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.17239179 |
| 107 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.16577155 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15475064 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15214533 |
| 110 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13504794 |
| 111 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13338382 |
| 112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12777250 |
| 113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11143879 |
| 114 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.09877979 |
| 115 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09816471 |
| 116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09496342 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09373819 |
| 118 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09313120 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08988814 |
| 120 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07586929 |
| 121 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07181196 |
| 122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06897590 |
| 123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06735898 |
| 124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06584331 |
| 125 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06119532 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05621178 |
| 127 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.03223614 |
| 128 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02586438 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02060790 |
| 130 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02060625 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01918806 |
| 132 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01777840 |
| 133 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.01389691 |
| 134 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.01229803 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00682238 |
| 136 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00413307 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00337251 |
| 138 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99213012 |
| 139 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98373113 |
| 140 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98176515 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97760335 |
| 142 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97513048 |
| 143 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97478117 |
| 144 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95935527 |
| 145 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95922881 |
| 146 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95686699 |
| 147 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95389200 |
| 148 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95374167 |
| 149 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94280225 |
| 150 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94017894 |
| 151 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.93350767 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93203987 |
| 153 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93024342 |
| 154 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92806159 |
| 155 | MAF_26560356_Chip-Seq_TH1_Human | 0.92414472 |
| 156 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92226807 |
| 157 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91327280 |
| 158 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90545952 |
| 159 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90335880 |
| 160 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90214589 |
| 161 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89502997 |
| 162 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89440508 |
| 163 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89365494 |
| 164 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89316817 |
| 165 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88636582 |
| 166 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.88476597 |
| 167 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87766123 |
| 168 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87536817 |
| 169 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87438683 |
| 170 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87096314 |
| 171 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87087406 |
| 172 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.86862295 |
| 173 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86802669 |
| 174 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86611900 |
| 175 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85462564 |
| 176 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.85249055 |
| 177 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84333660 |
| 178 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83821061 |
| 179 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82167236 |
| 180 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81505147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 6.56505684 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.64478901 |
| 3 | MP0003646_muscle_fatigue | 4.41754709 |
| 4 | MP0003724_increased_susceptibility_to | 3.60899970 |
| 5 | MP0000751_myopathy | 3.57825508 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.44626153 |
| 7 | MP0008004_abnormal_stomach_pH | 3.41102217 |
| 8 | MP0000465_gastrointestinal_hemorrhage | 3.36787477 |
| 9 | MP0004215_abnormal_myocardial_fiber | 3.29533658 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 3.20442659 |
| 11 | MP0004036_abnormal_muscle_relaxation | 3.00863036 |
| 12 | MP0003828_pulmonary_edema | 2.77323412 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.62742667 |
| 14 | MP0004270_analgesia | 2.41605096 |
| 15 | MP0003303_peritoneal_inflammation | 2.37951531 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.37798645 |
| 17 | MP0004130_abnormal_muscle_cell | 2.35231924 |
| 18 | MP0000749_muscle_degeneration | 2.27527811 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 2.25694860 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.23412280 |
| 21 | MP0002822_catalepsy | 2.20094708 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.18061602 |
| 23 | MP0004087_abnormal_muscle_fiber | 2.16403888 |
| 24 | MP0008775_abnormal_heart_ventricle | 2.11591676 |
| 25 | MP0000013_abnormal_adipose_tissue | 2.07218147 |
| 26 | MP0005620_abnormal_muscle_contractility | 1.97147736 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.97122323 |
| 28 | MP0002972_abnormal_cardiac_muscle | 1.95940322 |
| 29 | MP0001800_abnormal_humoral_immune | 1.95070886 |
| 30 | MP0001984_abnormal_olfaction | 1.94363243 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 1.92623869 |
| 32 | MP0002398_abnormal_bone_marrow | 1.92093269 |
| 33 | MP0005330_cardiomyopathy | 1.90591322 |
| 34 | MP0003436_decreased_susceptibility_to | 1.90103130 |
| 35 | MP0002269_muscular_atrophy | 1.81843427 |
| 36 | MP0004233_abnormal_muscle_weight | 1.80600080 |
| 37 | MP0004484_altered_response_of | 1.76657613 |
| 38 | MP0003137_abnormal_impulse_conducting | 1.74737921 |
| 39 | MP0004085_abnormal_heartbeat | 1.73938597 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.73272199 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.73272199 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.72406631 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.71990309 |
| 44 | MP0004510_myositis | 1.67829632 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.67472718 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.66274067 |
| 47 | MP0002723_abnormal_immune_serum | 1.65095507 |
| 48 | MP0003866_abnormal_defecation | 1.64686086 |
| 49 | MP0008961_abnormal_basal_metabolism | 1.63537672 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.63302035 |
| 51 | MP0002106_abnormal_muscle_physiology | 1.61024949 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.60896978 |
| 53 | MP0001851_eye_inflammation | 1.59450875 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.58732454 |
| 55 | MP0001819_abnormal_immune_cell | 1.58470289 |
| 56 | MP0000747_muscle_weakness | 1.57242485 |
| 57 | MP0004947_skin_inflammation | 1.56804786 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.54483091 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.54357644 |
| 60 | MP0005671_abnormal_response_to | 1.53097175 |
| 61 | MP0002452_abnormal_antigen_presenting | 1.52981039 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.51684095 |
| 63 | MP0000759_abnormal_skeletal_muscle | 1.51273131 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.50070122 |
| 65 | MP0004858_abnormal_nervous_system | 1.49111938 |
| 66 | MP0003221_abnormal_cardiomyocyte_apopto | 1.48641396 |
| 67 | MP0010630_abnormal_cardiac_muscle | 1.47441906 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.47112236 |
| 69 | MP0001544_abnormal_cardiovascular_syste | 1.46311205 |
| 70 | MP0005385_cardiovascular_system_phenoty | 1.46311205 |
| 71 | MP0002063_abnormal_learning/memory/cond | 1.44378953 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 1.43076807 |
| 73 | MP0002419_abnormal_innate_immunity | 1.43066206 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.42911641 |
| 75 | MP0002722_abnormal_immune_system | 1.41911789 |
| 76 | MP0006138_congestive_heart_failure | 1.40616490 |
| 77 | MP0003329_amyloid_beta_deposits | 1.40143821 |
| 78 | MP0005666_abnormal_adipose_tissue | 1.39465861 |
| 79 | MP0000716_abnormal_immune_system | 1.38239855 |
| 80 | MP0008569_lethality_at_weaning | 1.36617110 |
| 81 | MP0009046_muscle_twitch | 1.36189122 |
| 82 | MP0002733_abnormal_thermal_nociception | 1.33522863 |
| 83 | MP0006072_abnormal_retinal_apoptosis | 1.33230689 |
| 84 | MP0000015_abnormal_ear_pigmentation | 1.33218777 |
| 85 | MP0000230_abnormal_systemic_arterial | 1.31631693 |
| 86 | MP0004924_abnormal_behavior | 1.31454958 |
| 87 | MP0005386_behavior/neurological_phenoty | 1.31454958 |
| 88 | MP0000703_abnormal_thymus_morphology | 1.28569536 |
| 89 | MP0003183_abnormal_peptide_metabolism | 1.28145685 |
| 90 | MP0002429_abnormal_blood_cell | 1.27991285 |
| 91 | MP0005369_muscle_phenotype | 1.27541712 |
| 92 | MP0005375_adipose_tissue_phenotype | 1.26399843 |
| 93 | MP0002272_abnormal_nervous_system | 1.25153060 |
| 94 | MP0005387_immune_system_phenotype | 1.23611339 |
| 95 | MP0001790_abnormal_immune_system | 1.23611339 |
| 96 | MP0001970_abnormal_pain_threshold | 1.20926387 |
| 97 | MP0005187_abnormal_penis_morphology | 1.19929312 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 1.17802450 |
| 99 | MP0002234_abnormal_pharynx_morphology | 1.17117219 |
| 100 | MP0005670_abnormal_white_adipose | 1.16812534 |
| 101 | MP0002332_abnormal_exercise_endurance | 1.14657059 |
| 102 | MP0005174_abnormal_tail_pigmentation | 1.14538163 |
| 103 | MP0005025_abnormal_response_to | 1.14282629 |
| 104 | MP0001533_abnormal_skeleton_physiology | 1.13393672 |
| 105 | MP0009745_abnormal_behavioral_response | 1.12624039 |
| 106 | MP0002067_abnormal_sensory_capabilities | 1.12481368 |
| 107 | MP0000750_abnormal_muscle_regeneration | 1.11312911 |
| 108 | MP0004811_abnormal_neuron_physiology | 1.08999442 |
| 109 | MP0002184_abnormal_innervation | 1.08852317 |
| 110 | MP0005409_darkened_coat_color | 1.07059929 |
| 111 | MP0002405_respiratory_system_inflammati | 1.06834179 |
| 112 | MP0009763_increased_sensitivity_to | 1.06798465 |
| 113 | MP0004043_abnormal_pH_regulation | 1.05065746 |
| 114 | MP0003045_fibrosis | 1.04083727 |
| 115 | MP0008874_decreased_physiological_sensi | 1.03511323 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 1.02859354 |
| 117 | MP0002736_abnormal_nociception_after | 1.02781034 |
| 118 | MP0005551_abnormal_eye_electrophysiolog | 1.01840762 |
| 119 | MP0002127_abnormal_cardiovascular_syste | 1.01837678 |
| 120 | MP0002572_abnormal_emotion/affect_behav | 1.00819205 |
| 121 | MP0001845_abnormal_inflammatory_respons | 1.00514297 |
| 122 | MP0002064_seizures | 1.00297492 |
| 123 | MP0005646_abnormal_pituitary_gland | 0.99183487 |
| 124 | MP0005423_abnormal_somatic_nervous | 0.98705690 |
| 125 | MP0000249_abnormal_blood_vessel | 0.97837601 |
| 126 | MP0000685_abnormal_immune_system | 0.96699868 |
| 127 | MP0001486_abnormal_startle_reflex | 0.96425882 |
| 128 | MP0005535_abnormal_body_temperature | 0.94692892 |
| 129 | MP0001502_abnormal_circadian_rhythm | 0.94494482 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.93423372 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.93064405 |
| 132 | MP0009333_abnormal_splenocyte_physiolog | 0.91689052 |
| 133 | MP0008877_abnormal_DNA_methylation | 0.91641971 |
| 134 | MP0003787_abnormal_imprinting | 0.88417467 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.87723175 |
| 136 | MP0000955_abnormal_spinal_cord | 0.87634859 |
| 137 | MP0003705_abnormal_hypodermis_morpholog | 0.87360849 |
| 138 | MP0002078_abnormal_glucose_homeostasis | 0.86540297 |
| 139 | MP0003879_abnormal_hair_cell | 0.85725871 |
| 140 | MP0002971_abnormal_brown_adipose | 0.85574727 |
| 141 | MP0006276_abnormal_autonomic_nervous | 0.85044429 |
| 142 | MP0000343_altered_response_to | 0.84969386 |
| 143 | MP0009697_abnormal_copulation | 0.84239143 |
| 144 | MP0002229_neurodegeneration | 0.82819752 |
| 145 | MP0009278_abnormal_bone_marrow | 0.82702340 |
| 146 | MP0002998_abnormal_bone_remodeling | 0.82082385 |
| 147 | MP0003633_abnormal_nervous_system | 0.80019158 |
| 148 | MP0004134_abnormal_chest_morphology | 0.80010456 |
| 149 | MP0003656_abnormal_erythrocyte_physiolo | 0.78509274 |
| 150 | MP0004883_abnormal_blood_vessel | 0.77442230 |
| 151 | MP0004147_increased_porphyrin_level | 0.76729757 |
| 152 | MP0002882_abnormal_neuron_morphology | 0.76519482 |
| 153 | MP0001440_abnormal_grooming_behavior | 0.75543266 |
| 154 | MP0002132_abnormal_respiratory_system | 0.75538225 |
| 155 | MP0005410_abnormal_fertilization | 0.74830454 |
| 156 | MP0001501_abnormal_sleep_pattern | 0.73521579 |
| 157 | MP0005165_increased_susceptibility_to | 0.73215186 |
| 158 | MP0002066_abnormal_motor_capabilities/c | 0.72627234 |
| 159 | MP0003880_abnormal_central_pattern | 0.72414776 |
| 160 | MP0002009_preneoplasia | 0.72414463 |
| 161 | MP0000266_abnormal_heart_morphology | 0.71748878 |
| 162 | MP0003638_abnormal_response/metabolism_ | 0.71380897 |
| 163 | MP0003091_abnormal_cell_migration | 0.70008993 |
| 164 | MP0002090_abnormal_vision | 0.69761332 |
| 165 | MP0003300_gastrointestinal_ulcer | 0.69203884 |
| 166 | MP0002557_abnormal_social/conspecific_i | 0.68739669 |
| 167 | MP0001986_abnormal_taste_sensitivity | 0.68557454 |
| 168 | MP0010368_abnormal_lymphatic_system | 0.66082238 |
| 169 | MP0009764_decreased_sensitivity_to | 0.65915879 |
| 170 | MP0005075_abnormal_melanosome_morpholog | 0.65368269 |
| 171 | MP0001663_abnormal_digestive_system | 0.65056426 |
| 172 | MP0001529_abnormal_vocalization | 0.64800171 |
| 173 | MP0001765_abnormal_ion_homeostasis | 0.64125618 |
| 174 | MP0003252_abnormal_bile_duct | 0.64047894 |
| 175 | MP0004381_abnormal_hair_follicle | 0.63749388 |
| 176 | MP0008872_abnormal_physiological_respon | 0.63742020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 9.19066047 |
| 2 | Increased mean platelet volume (HP:0011877) | 7.43304647 |
| 3 | Petechiae (HP:0000967) | 7.23712606 |
| 4 | Menorrhagia (HP:0000132) | 7.19886909 |
| 5 | Abnormal platelet volume (HP:0011876) | 7.15765982 |
| 6 | Epistaxis (HP:0000421) | 6.42635838 |
| 7 | Gingival bleeding (HP:0000225) | 6.07447665 |
| 8 | Purpura (HP:0000979) | 5.57732341 |
| 9 | Sudden death (HP:0001699) | 5.01166315 |
| 10 | Abnormal platelet function (HP:0011869) | 4.51928717 |
| 11 | Impaired platelet aggregation (HP:0003540) | 4.51928717 |
| 12 | Exercise-induced myalgia (HP:0003738) | 4.09712539 |
| 13 | Bundle branch block (HP:0011710) | 4.09532315 |
| 14 | Spontaneous hematomas (HP:0007420) | 4.05487633 |
| 15 | Atrial fibrillation (HP:0005110) | 4.00551100 |
| 16 | Ventricular fibrillation (HP:0001663) | 3.97315231 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 3.91417214 |
| 18 | Syncope (HP:0001279) | 3.87959062 |
| 19 | Primary atrial arrhythmia (HP:0001692) | 3.80144674 |
| 20 | Prolonged QT interval (HP:0001657) | 3.74465165 |
| 21 | Supraventricular tachycardia (HP:0004755) | 3.55424197 |
| 22 | Myokymia (HP:0002411) | 3.52105754 |
| 23 | Supraventricular arrhythmia (HP:0005115) | 3.48586666 |
| 24 | Myoglobinuria (HP:0002913) | 3.46843582 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.46774738 |
| 26 | Muscle fiber splitting (HP:0003555) | 3.46384330 |
| 27 | Difficulty running (HP:0009046) | 3.41299130 |
| 28 | Exercise-induced muscle cramps (HP:0003710) | 3.40373791 |
| 29 | Poikilocytosis (HP:0004447) | 3.40175710 |
| 30 | Ventricular tachycardia (HP:0004756) | 3.32743518 |
| 31 | Calf muscle hypertrophy (HP:0008981) | 3.21637702 |
| 32 | Acanthocytosis (HP:0001927) | 3.18199700 |
| 33 | Central scotoma (HP:0000603) | 3.12476193 |
| 34 | Atrioventricular block (HP:0001678) | 3.10937938 |
| 35 | Dysmetric saccades (HP:0000641) | 3.09348894 |
| 36 | Heart block (HP:0012722) | 3.08087006 |
| 37 | Action tremor (HP:0002345) | 3.05572296 |
| 38 | Ventricular arrhythmia (HP:0004308) | 3.04570049 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.99668408 |
| 40 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.95405376 |
| 41 | Right ventricular cardiomyopathy (HP:0011663) | 2.95121623 |
| 42 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.93996406 |
| 43 | Palpitations (HP:0001962) | 2.92288035 |
| 44 | Myotonia (HP:0002486) | 2.91748285 |
| 45 | Pheochromocytoma (HP:0002666) | 2.90236313 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.85350468 |
| 47 | Bruising susceptibility (HP:0000978) | 2.84280009 |
| 48 | Abnormal atrioventricular conduction (HP:0005150) | 2.83856713 |
| 49 | Abnormal EKG (HP:0003115) | 2.81352359 |
| 50 | Stomatitis (HP:0010280) | 2.80900980 |
| 51 | Conjunctival telangiectasia (HP:0000524) | 2.76523497 |
| 52 | Abnormality of the calf musculature (HP:0001430) | 2.74378429 |
| 53 | Lipoatrophy (HP:0100578) | 2.68657818 |
| 54 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.68117040 |
| 55 | T lymphocytopenia (HP:0005403) | 2.66385467 |
| 56 | Subaortic stenosis (HP:0001682) | 2.63381667 |
| 57 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.63381667 |
| 58 | Eczematoid dermatitis (HP:0000976) | 2.60361595 |
| 59 | Dyschromatopsia (HP:0007641) | 2.59398053 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.58624989 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.51421738 |
| 62 | Visual hallucinations (HP:0002367) | 2.49934066 |
| 63 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.49191816 |
| 64 | EMG: myopathic abnormalities (HP:0003458) | 2.48594539 |
| 65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.47715631 |
| 66 | Insidious onset (HP:0003587) | 2.46552686 |
| 67 | Termporal pattern (HP:0011008) | 2.46552686 |
| 68 | Asymmetric septal hypertrophy (HP:0001670) | 2.45709186 |
| 69 | Hypercortisolism (HP:0001578) | 2.44865641 |
| 70 | Ketoacidosis (HP:0001993) | 2.43040399 |
| 71 | Ulnar claw (HP:0001178) | 2.40570649 |
| 72 | Increased connective tissue (HP:0009025) | 2.39038048 |
| 73 | Focal seizures (HP:0007359) | 2.38838425 |
| 74 | Long toe (HP:0010511) | 2.38575614 |
| 75 | Papillary thyroid carcinoma (HP:0002895) | 2.38575562 |
| 76 | Neuroendocrine neoplasm (HP:0100634) | 2.37699696 |
| 77 | Focal motor seizures (HP:0011153) | 2.35476815 |
| 78 | Dilated cardiomyopathy (HP:0001644) | 2.32595221 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.32522980 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.32286610 |
| 81 | Inflammation of the large intestine (HP:0002037) | 2.31122697 |
| 82 | Depression (HP:0000716) | 2.31040486 |
| 83 | Chest pain (HP:0100749) | 2.30729942 |
| 84 | Hyperglycemia (HP:0003074) | 2.29439137 |
| 85 | Difficulty climbing stairs (HP:0003551) | 2.29385900 |
| 86 | Arterial thrombosis (HP:0004420) | 2.29121792 |
| 87 | Hamartoma of the eye (HP:0010568) | 2.24982601 |
| 88 | Resting tremor (HP:0002322) | 2.24770752 |
| 89 | EMG: neuropathic changes (HP:0003445) | 2.23444202 |
| 90 | Truncal ataxia (HP:0002078) | 2.22306120 |
| 91 | Abnormal pupillary function (HP:0007686) | 2.21805470 |
| 92 | Abnormality of binocular vision (HP:0011514) | 2.20795227 |
| 93 | Diplopia (HP:0000651) | 2.20795227 |
| 94 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.19818756 |
| 95 | Nemaline bodies (HP:0003798) | 2.19275369 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.19099756 |
| 97 | Febrile seizures (HP:0002373) | 2.18078589 |
| 98 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.14648342 |
| 99 | Encephalitis (HP:0002383) | 2.14031677 |
| 100 | Recurrent abscess formation (HP:0002722) | 2.13701092 |
| 101 | Recurrent fungal infections (HP:0002841) | 2.12987572 |
| 102 | Atonic seizures (HP:0010819) | 2.11835611 |
| 103 | Abnormality of T cells (HP:0002843) | 2.11356640 |
| 104 | Urinary urgency (HP:0000012) | 2.11333183 |
| 105 | Left ventricular hypertrophy (HP:0001712) | 2.10972550 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 2.10262475 |
| 107 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09508113 |
| 108 | Thrombocytosis (HP:0001894) | 2.08616858 |
| 109 | Muscle stiffness (HP:0003552) | 2.07714142 |
| 110 | Joint swelling (HP:0001386) | 2.07187162 |
| 111 | Thyroid carcinoma (HP:0002890) | 2.06300579 |
| 112 | Recurrent viral infections (HP:0004429) | 2.06101781 |
| 113 | Chronic diarrhea (HP:0002028) | 2.05566977 |
| 114 | Obstructive lung disease (HP:0006536) | 2.04707479 |
| 115 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04707479 |
| 116 | Muscle fiber inclusion bodies (HP:0100299) | 2.04008552 |
| 117 | Abnormality of the prostate (HP:0008775) | 2.03229609 |
| 118 | Scotoma (HP:0000575) | 2.03017270 |
| 119 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.02022530 |
| 120 | Rhabdomyolysis (HP:0003201) | 2.00692895 |
| 121 | Abnormality of the foot musculature (HP:0001436) | 2.00682455 |
| 122 | Colitis (HP:0002583) | 1.99949129 |
| 123 | Spontaneous abortion (HP:0005268) | 1.99702826 |
| 124 | Rapidly progressive (HP:0003678) | 1.99380433 |
| 125 | Congenital stationary night blindness (HP:0007642) | 1.98820065 |
| 126 | Pustule (HP:0200039) | 1.98685714 |
| 127 | Ankle clonus (HP:0011448) | 1.98506339 |
| 128 | Tinnitus (HP:0000360) | 1.98361905 |
| 129 | Male infertility (HP:0003251) | 1.97958352 |
| 130 | Hypoglycemic coma (HP:0001325) | 1.96353307 |
| 131 | Dysdiadochokinesis (HP:0002075) | 1.94949142 |
| 132 | Hammertoe (HP:0001765) | 1.94660896 |
| 133 | Recurrent bacterial skin infections (HP:0005406) | 1.93097668 |
| 134 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92483188 |
| 135 | Leukocytosis (HP:0001974) | 1.91915110 |
| 136 | Neoplasm of the heart (HP:0100544) | 1.88897070 |
| 137 | Steppage gait (HP:0003376) | 1.86673317 |
| 138 | Abnormality of the lower motor neuron (HP:0002366) | 1.86472538 |
| 139 | Absence seizures (HP:0002121) | 1.86254640 |
| 140 | Distal lower limb amyotrophy (HP:0008944) | 1.85957105 |
| 141 | Generalized tonic-clonic seizures (HP:0002069) | 1.85810227 |
| 142 | Progressive cerebellar ataxia (HP:0002073) | 1.85372810 |
| 143 | Insomnia (HP:0100785) | 1.85249650 |
| 144 | Granulocytopenia (HP:0001913) | 1.85119323 |
| 145 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.84937009 |
| 146 | Postural instability (HP:0002172) | 1.84406999 |
| 147 | Anxiety (HP:0000739) | 1.83435456 |
| 148 | Upper limb muscle weakness (HP:0003484) | 1.82426238 |
| 149 | Paralysis (HP:0003470) | 1.82019239 |
| 150 | Abnormality of iron homeostasis (HP:0011031) | 1.81727385 |
| 151 | Supranuclear gaze palsy (HP:0000605) | 1.79988401 |
| 152 | Meningitis (HP:0001287) | 1.79900620 |
| 153 | Myositis (HP:0100614) | 1.79716476 |
| 154 | Aortic aneurysm (HP:0004942) | 1.79656080 |
| 155 | Enlarged penis (HP:0000040) | 1.79527376 |
| 156 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.79458547 |
| 157 | Polycythemia (HP:0001901) | 1.78863521 |
| 158 | Papilledema (HP:0001085) | 1.78752256 |
| 159 | Vertigo (HP:0002321) | 1.78730293 |
| 160 | Impaired social interactions (HP:0000735) | 1.78393744 |
| 161 | Abnormal social behavior (HP:0012433) | 1.78393744 |
| 162 | Acute myeloid leukemia (HP:0004808) | 1.77686902 |
| 163 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.77149682 |
| 164 | Hyperthyroidism (HP:0000836) | 1.76490549 |
| 165 | Cholelithiasis (HP:0001081) | 1.75817677 |
| 166 | Stomach cancer (HP:0012126) | 1.75668118 |
| 167 | Lower limb amyotrophy (HP:0007210) | 1.74246063 |
| 168 | Areflexia of lower limbs (HP:0002522) | 1.74213628 |
| 169 | Acute hepatic failure (HP:0006554) | 1.73963254 |
| 170 | Abnormality of T cell physiology (HP:0011840) | 1.73380959 |
| 171 | Upper limb amyotrophy (HP:0009129) | 1.72866220 |
| 172 | Distal upper limb amyotrophy (HP:0007149) | 1.72866220 |
| 173 | Mask-like facies (HP:0000298) | 1.72380932 |
| 174 | Cerebral aneurysm (HP:0004944) | 1.72371646 |
| 175 | Cellulitis (HP:0100658) | 1.70128209 |
| 176 | Eosinophilia (HP:0001880) | 1.65254718 |
| 177 | Fatigue (HP:0012378) | 1.62281089 |
| 178 | Vasculitis (HP:0002633) | 1.61839867 |
| 179 | Verrucae (HP:0200043) | 1.60793306 |
| 180 | Papilloma (HP:0012740) | 1.60793306 |
| 181 | Abnormality of macrophages (HP:0004311) | 1.60712611 |
| 182 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.59635928 |
| 183 | Increased density of long bones (HP:0006392) | 1.59562071 |
| 184 | Poor eye contact (HP:0000817) | 1.56788510 |
| 185 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.56458737 |
| 186 | Episodic fever (HP:0001954) | 1.55042461 |
| 187 | Albinism (HP:0001022) | 1.52801231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.05971199 |
| 2 | MAP3K9 | 3.34103403 |
| 3 | KSR2 | 3.23429013 |
| 4 | TEC | 3.21748586 |
| 5 | LMTK2 | 2.97452747 |
| 6 | TRIB3 | 2.78217934 |
| 7 | BTK | 2.76356107 |
| 8 | PIK3CG | 2.69053264 |
| 9 | SYK | 2.47812931 |
| 10 | PHKG1 | 2.43441598 |
| 11 | PHKG2 | 2.43441598 |
| 12 | FES | 2.29191581 |
| 13 | MAP3K4 | 2.21094577 |
| 14 | MST4 | 2.15948551 |
| 15 | PRKD3 | 2.14344317 |
| 16 | BMPR2 | 2.10953594 |
| 17 | PAK6 | 2.10362682 |
| 18 | TTN | 2.06194270 |
| 19 | MAP2K3 | 2.02510821 |
| 20 | DMPK | 1.93489974 |
| 21 | ITK | 1.91595652 |
| 22 | NTRK3 | 1.89732254 |
| 23 | TAOK1 | 1.85745365 |
| 24 | LATS2 | 1.83631313 |
| 25 | MAPKAPK3 | 1.83617852 |
| 26 | ZAP70 | 1.76904011 |
| 27 | RIPK1 | 1.72155268 |
| 28 | HCK | 1.70624981 |
| 29 | CAMK1G | 1.70010258 |
| 30 | MYLK | 1.65539700 |
| 31 | EEF2K | 1.61390061 |
| 32 | BMX | 1.60692663 |
| 33 | OBSCN | 1.56525997 |
| 34 | PINK1 | 1.56157590 |
| 35 | CAMK1D | 1.55051942 |
| 36 | RET | 1.54594493 |
| 37 | PRPF4B | 1.54300321 |
| 38 | TXK | 1.52091148 |
| 39 | MINK1 | 1.51410694 |
| 40 | MAP2K4 | 1.46576485 |
| 41 | PDK3 | 1.45961637 |
| 42 | PDK4 | 1.45961637 |
| 43 | GRK6 | 1.45833451 |
| 44 | PKN2 | 1.45596146 |
| 45 | MAP3K13 | 1.45173435 |
| 46 | STK38 | 1.44271168 |
| 47 | MAP4K1 | 1.42317172 |
| 48 | MAP3K14 | 1.38959314 |
| 49 | JAK3 | 1.37691296 |
| 50 | CSF1R | 1.36874423 |
| 51 | NEK1 | 1.35828066 |
| 52 | MAP3K6 | 1.30517247 |
| 53 | NTRK1 | 1.29166093 |
| 54 | KSR1 | 1.26490789 |
| 55 | MAP3K2 | 1.22115525 |
| 56 | PAK3 | 1.18658734 |
| 57 | INSRR | 1.18052059 |
| 58 | LATS1 | 1.15197440 |
| 59 | AKT3 | 1.15101436 |
| 60 | CAMKK1 | 1.13504771 |
| 61 | KIT | 1.09856336 |
| 62 | RAF1 | 1.09115791 |
| 63 | SGK3 | 1.08764234 |
| 64 | PRKAA1 | 1.08345636 |
| 65 | LYN | 1.07564469 |
| 66 | TRPM7 | 1.05917487 |
| 67 | EPHA4 | 1.05697870 |
| 68 | SGK2 | 1.03251818 |
| 69 | EPHA3 | 1.02345184 |
| 70 | IKBKB | 1.01850805 |
| 71 | PRKCH | 1.00665540 |
| 72 | WNK1 | 1.00412083 |
| 73 | MAP3K7 | 1.00277225 |
| 74 | LCK | 0.97996240 |
| 75 | ARAF | 0.94813326 |
| 76 | FRK | 0.92008900 |
| 77 | SGK494 | 0.91879505 |
| 78 | SGK223 | 0.91879505 |
| 79 | IKBKE | 0.91653546 |
| 80 | DAPK2 | 0.90395044 |
| 81 | CDC42BPA | 0.89707929 |
| 82 | MAP3K1 | 0.88894288 |
| 83 | PRKAA2 | 0.88728885 |
| 84 | CAMKK2 | 0.88585057 |
| 85 | PDGFRA | 0.87669984 |
| 86 | MAP2K7 | 0.85239824 |
| 87 | MUSK | 0.84452009 |
| 88 | DYRK1A | 0.83299999 |
| 89 | PLK2 | 0.83085058 |
| 90 | CDK12 | 0.82565129 |
| 91 | MARK2 | 0.82528124 |
| 92 | HIPK2 | 0.81909581 |
| 93 | EIF2AK3 | 0.80308682 |
| 94 | SCYL2 | 0.77529410 |
| 95 | FLT3 | 0.77000242 |
| 96 | PIK3CA | 0.76524630 |
| 97 | MAPK7 | 0.74769515 |
| 98 | CDK5 | 0.74678305 |
| 99 | NTRK2 | 0.74510092 |
| 100 | MARK3 | 0.73963188 |
| 101 | BCKDK | 0.73626060 |
| 102 | BLK | 0.72002236 |
| 103 | PIM1 | 0.71624627 |
| 104 | PRKD1 | 0.71347934 |
| 105 | WNK4 | 0.71200033 |
| 106 | CSK | 0.70441534 |
| 107 | MAP2K1 | 0.69872248 |
| 108 | CDK9 | 0.66879409 |
| 109 | TNK2 | 0.66814098 |
| 110 | EIF2AK1 | 0.65885726 |
| 111 | TYRO3 | 0.65480786 |
| 112 | MATK | 0.65287083 |
| 113 | PRKCQ | 0.65004669 |
| 114 | RPS6KA2 | 0.64603187 |
| 115 | PDK1 | 0.63882728 |
| 116 | IRAK1 | 0.62790426 |
| 117 | MAP3K3 | 0.62747716 |
| 118 | PDPK1 | 0.62373222 |
| 119 | TIE1 | 0.62082511 |
| 120 | STK3 | 0.62052894 |
| 121 | TNIK | 0.62041843 |
| 122 | STK11 | 0.61091200 |
| 123 | TBK1 | 0.59884517 |
| 124 | TAOK3 | 0.59666004 |
| 125 | GRK5 | 0.57565099 |
| 126 | FGR | 0.57353783 |
| 127 | PRKD2 | 0.57011256 |
| 128 | NLK | 0.56338942 |
| 129 | YES1 | 0.54080563 |
| 130 | FYN | 0.53373136 |
| 131 | FER | 0.51862212 |
| 132 | CAMK1 | 0.50855555 |
| 133 | MAP3K5 | 0.49220703 |
| 134 | FGFR3 | 0.47065356 |
| 135 | MARK1 | 0.46637508 |
| 136 | ROCK1 | 0.46164738 |
| 137 | BRAF | 0.46021754 |
| 138 | CAMK2D | 0.45792027 |
| 139 | MAPK12 | 0.45465440 |
| 140 | CAMK2A | 0.44227086 |
| 141 | MAPK13 | 0.43478080 |
| 142 | JAK2 | 0.42784544 |
| 143 | RPS6KA3 | 0.41954486 |
| 144 | ABL1 | 0.41901208 |
| 145 | SGK1 | 0.40998597 |
| 146 | STK24 | 0.40735029 |
| 147 | MAPK11 | 0.40466576 |
| 148 | JAK1 | 0.39264792 |
| 149 | MAPK3 | 0.37779234 |
| 150 | MAPK10 | 0.37613900 |
| 151 | PAK2 | 0.37589643 |
| 152 | CAMK4 | 0.37223836 |
| 153 | MAPK4 | 0.36303725 |
| 154 | NUAK1 | 0.36211459 |
| 155 | PDK2 | 0.35254078 |
| 156 | STK4 | 0.35194700 |
| 157 | PTK2B | 0.35148658 |
| 158 | MAPKAPK5 | 0.35067363 |
| 159 | PDGFRB | 0.34825374 |
| 160 | CCNB1 | 0.33482482 |
| 161 | MTOR | 0.32401331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 3.88716247 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.60513509 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.26802406 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25486346 |
| 5 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.11969604 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.01622054 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96525713 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.95397893 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 1.86602038 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.84295860 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82051258 |
| 12 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.74975663 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.74145672 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.69081770 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.61503653 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.57152159 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.56264967 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.55434061 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.54375313 |
| 20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.50977815 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50079071 |
| 22 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49420496 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.49059541 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48696237 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46491001 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.44109446 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43788006 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.43652063 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.42934351 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.42736782 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.41726759 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.40258423 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40117200 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38232100 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.37088176 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.36631591 |
| 37 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.34494751 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34122674 |
| 39 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.33761938 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33588602 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32390361 |
| 42 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.31894229 |
| 43 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.31636317 |
| 44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.30085729 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.29827773 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29525758 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.28653157 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26886936 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26818252 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26690066 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.24003460 |
| 52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.22355051 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22306194 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21012449 |
| 55 | Taste transduction_Homo sapiens_hsa04742 | 1.19740708 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19671405 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18218026 |
| 58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.16800779 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 1.16708171 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13304897 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12621159 |
| 62 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10888820 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.10180272 |
| 64 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.08748993 |
| 65 | Gap junction_Homo sapiens_hsa04540 | 1.08574561 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08531683 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07443322 |
| 68 | Asthma_Homo sapiens_hsa05310 | 1.06721169 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06621191 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06417148 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 1.06407991 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06200187 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05807979 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00899721 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.00494477 |
| 76 | Glioma_Homo sapiens_hsa05214 | 1.00274196 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 1.00032522 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99541481 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97948502 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97829441 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95476712 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95363407 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95122611 |
| 84 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.93820033 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.93671865 |
| 86 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.93235477 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92422209 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91255035 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90318189 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.87953413 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.87654266 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.87235397 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.87016742 |
| 94 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86444804 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85859223 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85443211 |
| 97 | Shigellosis_Homo sapiens_hsa05131 | 0.83612866 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82576274 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81686999 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81647390 |
| 101 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80322597 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80031729 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.79863630 |
| 104 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.79799030 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79646796 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78900299 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78761564 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77238920 |
| 109 | Phototransduction_Homo sapiens_hsa04744 | 0.75913757 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75905200 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74986923 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74919942 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74813766 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74698684 |
| 115 | Hepatitis B_Homo sapiens_hsa05161 | 0.73941355 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73808271 |
| 117 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73401883 |
| 118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72308494 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71432742 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70411908 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70227806 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69584401 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68569457 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68519282 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67192581 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66422527 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66329495 |
| 128 | Alcoholism_Homo sapiens_hsa05034 | 0.62027914 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60292361 |
| 130 | Influenza A_Homo sapiens_hsa05164 | 0.60109125 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59875262 |
| 132 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58717545 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.57726168 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57344079 |
| 135 | Melanogenesis_Homo sapiens_hsa04916 | 0.56832152 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55868744 |
| 137 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54589951 |
| 138 | Bile secretion_Homo sapiens_hsa04976 | 0.52940331 |
| 139 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52480879 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.50043081 |
| 141 | Lysine degradation_Homo sapiens_hsa00310 | 0.50036306 |
| 142 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49527582 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48975530 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48007106 |
| 145 | Focal adhesion_Homo sapiens_hsa04510 | 0.47097638 |
| 146 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47043796 |
| 147 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45762372 |
| 148 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44971874 |
| 149 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42791365 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42772215 |

